Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Pharmacokinetics and safety of VALTOCO (NRL‐1; diazepam nasal spray) in patients with epilepsy during seizure (ictal/peri‐ictal) and nonseizure (interictal) conditions: A phase 1, open‐label study
Epilepsia ( IF 5.6 ) Pub Date : 2020-04-27 , DOI: 10.1111/epi.16506 Robert Edward Hogan 1 , Daniel Tarquinio 2 , Michael R Sperling 3 , Pavel Klein 4 , Ian Miller 5 , Eric B Segal 6 , Adrian L Rabinowicz 7 , Enrique Carrazana 8
Epilepsia ( IF 5.6 ) Pub Date : 2020-04-27 , DOI: 10.1111/epi.16506 Robert Edward Hogan 1 , Daniel Tarquinio 2 , Michael R Sperling 3 , Pavel Klein 4 , Ian Miller 5 , Eric B Segal 6 , Adrian L Rabinowicz 7 , Enrique Carrazana 8
Affiliation
To assess pharmacokinetics and safety of diazepam nasal spray (NRL‐1; VALTOCO®) in pediatric and adult patients with epilepsy in seizure and nonseizure states.
中文翻译：
VALTOCO（NRL-1；地西泮鼻喷雾剂）在癫痫发作（发作期/发作期）和非癫痫发作（发作间期）条件下的癫痫患者的药代动力学和安全性：1 期，开放标签研究
评估地西泮鼻喷雾剂（NRL-1；VALTOCO®）在癫痫发作和非癫痫发作状态的儿童和成人癫痫患者中的药代动力学和安全性。
更新日期：2020-04-27
中文翻译：
VALTOCO（NRL-1；地西泮鼻喷雾剂）在癫痫发作（发作期/发作期）和非癫痫发作（发作间期）条件下的癫痫患者的药代动力学和安全性：1 期，开放标签研究
评估地西泮鼻喷雾剂（NRL-1；VALTOCO®）在癫痫发作和非癫痫发作状态的儿童和成人癫痫患者中的药代动力学和安全性。
京公网安备 11010802027423号